真核枝孢菌l -天冬酰胺酶体外抗乳腺癌和结肠癌的细胞毒性研究。

IF 2.1 Q3 ONCOLOGY
Dina Johar, Hamido M Hefny, Moselhy S Mansy, Amal A I Mekawey, Mohammed S Abdulrahman, Samy Zaky
{"title":"真核枝孢菌l -天冬酰胺酶体外抗乳腺癌和结肠癌的细胞毒性研究。","authors":"Dina Johar, Hamido M Hefny, Moselhy S Mansy, Amal A I Mekawey, Mohammed S Abdulrahman, Samy Zaky","doi":"10.1186/s43046-025-00270-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Recent statistical analyses indicate a rapid increase in the incidence of breast and colon cancer in Egypt. Although invasive techniques have been widely employed for early detection, diagnosis, and intervention of those cancers, they are associated with inherent risks and limitations, which often result in various complications. Therefore, noninvasive screening methods are inevitable due to their accessibility, cost-effectiveness, and high patient compliance rates. The enzyme L-asparaginase catalyzes the conversion of L-asparagine to L-aspartic acid: key metabolite for tumor cell division, thereby demonstrating anticancer potential. However, the prolonged use of bacterial L-asparaginase may cause allergic reactions and side effects such as diabetes, leukopenia, and co-agglutination disorders. Exploring the anticancer properties of L-asparaginase from different species such as yeast and fungi has been proposed to mitigate these adverse effects.</p><p><strong>Objectives: </strong>This study aimed at extracting and optimizing the expression of L-asparaginase from the eukaryotic Cladosporium species, as to assess its anticancer potential against breast and colon cancer cell lines.</p><p><strong>Method: </strong>Cladosporium species were identified morphologically and then cultured on modified Czapek-Dox Agar (mCDA) medium supplemented with L-asparagine to induce L-asparaginase production. Submerged fermentation was employed to optimize enzyme production. The enzyme activity was quantified using the Nesslerization method, and its cytotoxicity against colon and breast cancer cell lines was assessed using the (MTT) assay.</p><p><strong>Results: </strong>Among the Cladosporium isolates, 18.4% exhibited positive plate assay test, with enzyme activities ranging from 255 to 428 U/mL. Immunoblotting using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis revealed single protein band of approximately 37 kDa, consistent with L-asparaginase activity. Cytotoxicity assay of purified L-asparaginase showed significant antiproliferative effects against breast cancer cell lines MCF-7 and MDA-MB-231, with IC<sub>50</sub> values of 36.26 and 45.7 µg/mL, respectively.</p><p><strong>Conclusion: </strong>Certain eukaryotic Cladosporium strains are potential sources for the anticancer L-asparaginase production.</p>","PeriodicalId":17301,"journal":{"name":"Journal of the Egyptian National Cancer Institute","volume":"37 1","pages":"33"},"PeriodicalIF":2.1000,"publicationDate":"2025-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cytotoxicity of L-asparaginase from eucaryotic Cladosporium species against breast and colon cancer in vitro.\",\"authors\":\"Dina Johar, Hamido M Hefny, Moselhy S Mansy, Amal A I Mekawey, Mohammed S Abdulrahman, Samy Zaky\",\"doi\":\"10.1186/s43046-025-00270-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Recent statistical analyses indicate a rapid increase in the incidence of breast and colon cancer in Egypt. Although invasive techniques have been widely employed for early detection, diagnosis, and intervention of those cancers, they are associated with inherent risks and limitations, which often result in various complications. Therefore, noninvasive screening methods are inevitable due to their accessibility, cost-effectiveness, and high patient compliance rates. The enzyme L-asparaginase catalyzes the conversion of L-asparagine to L-aspartic acid: key metabolite for tumor cell division, thereby demonstrating anticancer potential. However, the prolonged use of bacterial L-asparaginase may cause allergic reactions and side effects such as diabetes, leukopenia, and co-agglutination disorders. Exploring the anticancer properties of L-asparaginase from different species such as yeast and fungi has been proposed to mitigate these adverse effects.</p><p><strong>Objectives: </strong>This study aimed at extracting and optimizing the expression of L-asparaginase from the eukaryotic Cladosporium species, as to assess its anticancer potential against breast and colon cancer cell lines.</p><p><strong>Method: </strong>Cladosporium species were identified morphologically and then cultured on modified Czapek-Dox Agar (mCDA) medium supplemented with L-asparagine to induce L-asparaginase production. Submerged fermentation was employed to optimize enzyme production. The enzyme activity was quantified using the Nesslerization method, and its cytotoxicity against colon and breast cancer cell lines was assessed using the (MTT) assay.</p><p><strong>Results: </strong>Among the Cladosporium isolates, 18.4% exhibited positive plate assay test, with enzyme activities ranging from 255 to 428 U/mL. Immunoblotting using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis revealed single protein band of approximately 37 kDa, consistent with L-asparaginase activity. Cytotoxicity assay of purified L-asparaginase showed significant antiproliferative effects against breast cancer cell lines MCF-7 and MDA-MB-231, with IC<sub>50</sub> values of 36.26 and 45.7 µg/mL, respectively.</p><p><strong>Conclusion: </strong>Certain eukaryotic Cladosporium strains are potential sources for the anticancer L-asparaginase production.</p>\",\"PeriodicalId\":17301,\"journal\":{\"name\":\"Journal of the Egyptian National Cancer Institute\",\"volume\":\"37 1\",\"pages\":\"33\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2025-05-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the Egyptian National Cancer Institute\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1186/s43046-025-00270-6\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Egyptian National Cancer Institute","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s43046-025-00270-6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:最近的统计分析表明,乳腺癌和结肠癌的发病率在埃及迅速增加。虽然侵入性技术已被广泛用于这些癌症的早期发现、诊断和干预,但它们具有固有的风险和局限性,往往导致各种并发症。因此,无创筛查方法因其可及性、成本效益和患者的高依从性而成为必然。l -天冬酰胺酶催化l -天冬酰胺转化为l -天冬氨酸:肿瘤细胞分裂的关键代谢物,因此显示出抗癌潜力。然而,长期使用细菌l -天冬酰胺酶可能引起过敏反应和副作用,如糖尿病、白细胞减少症和共凝集障碍。从酵母和真菌等不同物种中探索l -天冬酰胺酶的抗癌特性已被提出以减轻这些不利影响。目的:从真核枝孢菌中提取l -天冬酰胺酶并优化其表达,评价其对乳腺癌和结肠癌细胞系的抗癌作用。方法:对枝孢菌进行形态鉴定,在添加l -天冬酰胺的改良Czapek-Dox琼脂(mCDA)培养基上培养,诱导产l -天冬酰胺酶。采用深层发酵优化产酶效果。用neslerization法测定酶活性,用MTT法测定其对结肠癌和乳腺癌细胞株的细胞毒性。结果:分枝孢菌分离株中,平板法检测阳性的占18.4%,酶活范围为255 ~ 428 U/mL。使用十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)进行免疫印迹分析显示,单蛋白条带约为37 kDa,与l -天冬酰胺酶活性一致。纯化后的l -天冬酰胺酶对乳腺癌细胞株MCF-7和MDA-MB-231具有显著的抗增殖作用,IC50值分别为36.26µg/mL和45.7µg/mL。结论:某些真核枝孢菌是产生抗癌l -天冬酰胺酶的潜在来源。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Cytotoxicity of L-asparaginase from eucaryotic Cladosporium species against breast and colon cancer in vitro.

Background: Recent statistical analyses indicate a rapid increase in the incidence of breast and colon cancer in Egypt. Although invasive techniques have been widely employed for early detection, diagnosis, and intervention of those cancers, they are associated with inherent risks and limitations, which often result in various complications. Therefore, noninvasive screening methods are inevitable due to their accessibility, cost-effectiveness, and high patient compliance rates. The enzyme L-asparaginase catalyzes the conversion of L-asparagine to L-aspartic acid: key metabolite for tumor cell division, thereby demonstrating anticancer potential. However, the prolonged use of bacterial L-asparaginase may cause allergic reactions and side effects such as diabetes, leukopenia, and co-agglutination disorders. Exploring the anticancer properties of L-asparaginase from different species such as yeast and fungi has been proposed to mitigate these adverse effects.

Objectives: This study aimed at extracting and optimizing the expression of L-asparaginase from the eukaryotic Cladosporium species, as to assess its anticancer potential against breast and colon cancer cell lines.

Method: Cladosporium species were identified morphologically and then cultured on modified Czapek-Dox Agar (mCDA) medium supplemented with L-asparagine to induce L-asparaginase production. Submerged fermentation was employed to optimize enzyme production. The enzyme activity was quantified using the Nesslerization method, and its cytotoxicity against colon and breast cancer cell lines was assessed using the (MTT) assay.

Results: Among the Cladosporium isolates, 18.4% exhibited positive plate assay test, with enzyme activities ranging from 255 to 428 U/mL. Immunoblotting using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis revealed single protein band of approximately 37 kDa, consistent with L-asparaginase activity. Cytotoxicity assay of purified L-asparaginase showed significant antiproliferative effects against breast cancer cell lines MCF-7 and MDA-MB-231, with IC50 values of 36.26 and 45.7 µg/mL, respectively.

Conclusion: Certain eukaryotic Cladosporium strains are potential sources for the anticancer L-asparaginase production.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.50
自引率
0.00%
发文量
46
审稿时长
11 weeks
期刊介绍: As the official publication of the National Cancer Institute, Cairo University, the Journal of the Egyptian National Cancer Institute (JENCI) is an open access peer-reviewed journal that publishes on the latest innovations in oncology and thereby, providing academics and clinicians a leading research platform. JENCI welcomes submissions pertaining to all fields of basic, applied and clinical cancer research. Main topics of interest include: local and systemic anticancer therapy (with specific interest on applied cancer research from developing countries); experimental oncology; early cancer detection; randomized trials (including negatives ones); and key emerging fields of personalized medicine, such as molecular pathology, bioinformatics, and biotechnologies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信